KFS
MRNA icon

Kelly Financial Services’s Moderna MRNA Stock Holding History

Kelly Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-344
Closed -$40.9K – 507
2024
Q2 		$40.9K Sell
344
-100
-23% -$12.7K 0.01% 251
2024
Q1 		$47.3K Buy
444
+100
+29% +$10.1K 0.02% 225
2023
Q4 		$34.2K Sell
344
-87
-20% -$7.32K 0.01% 248
2023
Q3 		$44.5K Hold
431
– – 0.02% 193
2023
Q2 		$52.4K Sell
431
-13
-3% -$1.73K 0.02% 180
2023
Q1 		$68.2K Buy
444
+269
+154% +$44.4K 0.03% 149
2022
Q4 		$31.4K Sell
175
-25
-13% -$4.09K 0.02% 219
2022
Q3 		$23.6K Buy
200
+25
+14% +$3.79K 0.01% 237
2022
Q2 		$25K Hold
175
– – 0.01% 232
2022
Q1 		$30.1K Sell
175
-13
-7% -$2.19K 0.01% 234
2021
Q4 		$47.7K Sell
188
-187
-50% -$54.7K 0.02% 180
2021
Q3 		$144K Sell
375
-87,743
-100% -$32.4M 0.08% 82
2021
Q2 		$375K Buy
88,118
+87,742
+23,336% +$15.7M 0.01% 220
2021
Q1 		$49.2K Sell
376
-9
-2% -$1.3K 0.03% 125
2020
Q4 		$40.2K Buy
385
+110
+40% +$11.1K 0.03% 134
2020
Q3 		$19.5K Sell
275
-129
-32% -$8.99K 0.01% 176
2020
Q2 		$25.9K Buy
404
+354
+708% +$19.4K 0.02% 133
2020
Q1 		$1.5K Buy
+50
New +$1.15K ﹤0.01% 414

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kelly Financial Services's MRNA Position: Q3 2024 in Review

Kelly Financial Services sold out of Moderna (MRNA) in Q3 2024, closing a stake of 344 shares — an estimated $40.9K sold.

Kelly Financial Services first reported a position in MRNA in Q1 2020 and held it in 18 quarters. The position peaked at $375K in Q2 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Kelly Financial Services reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 344 Moderna shares in Q3 2024, an estimated $40.9K.
  • Kelly Financial Services first reported a position in Moderna in Q1 2020 and held it in 18 quarters.
  • Kelly Financial Services's Moderna position peaked at $375K in Q2 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.